E.大腸菌検査市場：検査別、エンドユーザー別-2025-2030年の世界予測

E.大腸菌検査市場は、2023年に9億9,617万米ドルと評価され、2024年には10億9,686万米ドルに達すると予測され、CAGR 10.20%で成長し、2030年には19億6,626万米ドルに達すると予測されています。

E.大腸菌検査の範囲と定義には、大腸菌の存在を検出することを目的とした診断手順が含まれ、食品や水の安全性、医療診断、医薬品など、さまざまな分野で公衆衛生と安全を確保するために不可欠です。E.大腸菌検査の必要性は、大腸菌が深刻な病気や集団発生を引き起こす可能性があるため、厳格な安全プロトコルを求める規制当局や消費者の要望を満たすために最も重要です。E.大腸菌検査の治療用途は、迅速な診断が不可欠なヘルスケア、汚染を防ぐために厳しい検査基準が求められる食品産業、公共の安全にとって定期的なモニタリングが重要な水処理施設など、様々な最終用途分野に及んでいます。

市場成長は主に、食品や水を媒介とする疾病に対する意識の高まり、厳しい政府規制、検査方法の技術進歩、予防ヘルスケア重視の高まりに影響されます。最新の潜在機会は、迅速で費用対効果が高く、高感度な検査キットの開発、精度と効率を高めるための人工知能とラボオンチップ技術の統合にあります。また、大きな成長の可能性を秘めたアンメット・ニーズに対応するため、低所得地域への検査ソリューションの拡大にも力を注ぐべきです。しかし、高度な検査技術の高コスト、新興国地域のインフラ不足、規制上のハードルといった制約が、市場拡大の課題となっています。

技術革新と研究に最適な分野には、リアルタイムで結果が得られるポイントオブケア検査機器の開発が含まれ、これにより治療までの時間が短縮され、管理結果が改善されます。また、バイオインフォマティクスと次世代シーケンシングの研究により、大腸菌の検出と分類をより正確に行うことができます。市場の競争は激しく、技術革新の継続と戦略的合併を特徴とし、製品ポートフォリオの強化に重点が置かれています。このため、学術機関やヘルスケア機関との共同研究や共同研究に投資している企業は、この進化する情勢において競争優位に立てる可能性が高いです。

市場力学：急速に進化するE.大腸菌検査市場の主要市場インサイトを公開

E.大腸菌検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 下痢の発生件数の増加
  • 食品リコール件数の増加
  • コンビニエンス・フードの大幅な消費
• 市場抑制要因
  • 大腸菌検査における標準化の欠如
• 市場機会
  • 食品安全測定における革新的技術のイントロダクション
  • 病原体検査向上のためのPCR技術の継続的開発
• 市場の課題
  • 食品と水の検査に伴う高コスト

ポーターの5つの力：E.大腸菌検査市場をナビゲートする戦略的ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：E.大腸菌検査市場における外部からの影響の把握

外部マクロ環境要因は、E.大腸菌検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析E.大腸菌検査市場における競合情勢の把握

E.大腸菌検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスE.大腸菌検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、E.大腸菌検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨E.大腸菌検査市場における成功への道筋を描く

E.大腸菌検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 下痢の発生率増加
    • 食品リコール件数の増加
    • インスタント食品の大量消費
  • 抑制要因
    • 大腸菌検査の標準化の欠如
  • 機会
    • 食品安全測定における革新的技術のイントロダクション
    • 病原体検査の改善に向けたPCR技術の継続的な開発
  • 課題
    • 食品や水の検査にかかる高額な費用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 E.大腸菌検査市場テスト別

• 臨床
  • 酵素免疫測定法
  • ポリメラーゼ連鎖反応
• 環境
  • 酵素基質法
  • 膜ろ過
  • 多重管発酵

第7章 E.大腸菌検査市場：エンドユーザー別

• ボトル入り飲料水サプライヤー
• 診断検査室
• 政府機関
• 家庭用および飲料水供給業者
• 病院
• 廃水治療機関

第8章 南北アメリカのE.大腸菌検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のE.大腸菌検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのE.大腸菌検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioSpace, Inc.
• BIOTOXICITY
• Caisson Labs Inc.
• Corning Incorporated
• Cygnus Technologies by Maravai LifeSciences
• Enzo Life Sciences, Inc.
• F. Hoffmann-La Roche Ltd.
• Intertek Group PLC
• Lonza Group Ltd.
• Merck & Co., Inc
• Merck KGaA
• SGS SA
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. E. COLI TESTING MARKET RESEARCH PROCESS
• FIGURE 2. E. COLI TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. E. COLI TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL E. COLI TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL E. COLI TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. E. COLI TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL E. COLI TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL E. COLI TESTING MARKET SIZE, BY ENZYME SUBSTRATE METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL E. COLI TESTING MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL E. COLI TESTING MARKET SIZE, BY MULTIPLE TUBE FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL E. COLI TESTING MARKET SIZE, BY BOTTLED WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL E. COLI TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL E. COLI TESTING MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL E. COLI TESTING MARKET SIZE, BY HOME & DRINKING WATER SUPPLIERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL E. COLI TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL E. COLI TESTING MARKET SIZE, BY WASTE WATER TREATMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CANADA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 38. CANADA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 39. CANADA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 40. CANADA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES E. COLI TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. CHINA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 60. CHINA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 61. CHINA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 62. CHINA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. INDIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 64. INDIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 65. INDIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 66. INDIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA E. COLI TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ITALY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 133. ITALY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 134. ITALY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 135. ITALY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. POLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 149. POLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 150. POLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 151. POLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. QATAR E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 153. QATAR E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 154. QATAR E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 155. QATAR E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY TESTING, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY ENVIRONMENTAL, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM E. COLI TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. E. COLI TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. E. COLI TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The E. Coli Testing Market was valued at USD 996.17 million in 2023, expected to reach USD 1,096.86 million in 2024, and is projected to grow at a CAGR of 10.20%, to USD 1,966.26 million by 2030.

The scope and definition of E. Coli testing encompass diagnostic procedures aimed at detecting the presence of Escherichia coli bacteria, crucial for ensuring public health and safety across various sectors, including food and water safety, medical diagnostics, and pharmaceuticals. The necessity of E. Coli testing is paramount due to the bacterium's potential to cause severe illness and outbreaks, driving regulatory and consumer demand for rigorous safety protocols. Applications of E. Coli testing cover diverse end-use sectors such as healthcare settings where rapid diagnostics are essential, the food industry which demands stringent testing standards to prevent contamination, and water treatment facilities where regular monitoring is critical to public safety.

Market growth is primarily influenced by increasing awareness of food and waterborne diseases, stringent government regulations, technological advancements in testing methods, and a growing emphasis on preventive healthcare. The latest potential opportunities lie in the development of rapid, cost-effective, and highly sensitive testing kits, as well as the integration of artificial intelligence and lab-on-a-chip technologies to enhance accuracy and efficiency. Efforts should also be directed towards expanding testing solutions to lower-income regions, addressing an unmet need with significant growth potential. However, limitations such as high costs of advanced testing technologies, lack of infrastructure in developing regions, and regulatory hurdles can pose challenges to market expansion.

The best areas for innovation and research include the development of point-of-care testing devices that allow for real-time results, thereby reducing time-to-treatment and improving management outcomes. Also, exploring bioinformatics and next-generation sequencing can foster even more accurate detection and classification of E. Coli strains. The market nature is competitive, characterized by ongoing technological innovation and strategic mergers, focusing on enhancement of product portfolios. Thus, businesses investing in robust research and collaborations with academic and healthcare institutions are likely to gain a competitive edge in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving E. Coli Testing Market

The E. Coli Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of diarrhea
  • Rise in numbers of food recalls
  • Significant consumption of convenience foods
• Market Restraints
  • Lack of standardizations in E.coli testing
• Market Opportunities
  • Introduction of innovative technologies in food safety measurements
  • Ongoing developments of PCR technology for improved pathogen testing
• Market Challenges
  • Associated high cost of testing food and water

Porter's Five Forces: A Strategic Tool for Navigating the E. Coli Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the E. Coli Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the E. Coli Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the E. Coli Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the E. Coli Testing Market

A detailed market share analysis in the E. Coli Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the E. Coli Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the E. Coli Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the E. Coli Testing Market

A strategic analysis of the E. Coli Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the E. Coli Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioSpace, Inc., BIOTOXICITY, Caisson Labs Inc., Corning Incorporated, Cygnus Technologies by Maravai LifeSciences, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Intertek Group PLC, Lonza Group Ltd., Merck & Co., Inc, Merck KGaA, SGS SA, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the E. Coli Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Testing, market is studied across Clinical and Environmental. The Clinical is further studied across Enzyme Immunoassays and Polymerase Chain Reaction. The Environmental is further studied across Enzyme Substrate Methods, Membrane Filtration, and Multiple Tube Fermentation.
• Based on End-User, market is studied across Bottled Water Suppliers, Diagnostic Laboratories, Government Agencies, Home & Drinking Water Suppliers, Hospitals, and Waste Water Treatment Agencies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of diarrhea
    • 5.1.1.2. Rise in numbers of food recalls
    • 5.1.1.3. Significant consumption of convenience foods
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standardizations in E.coli testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of innovative technologies in food safety measurements
    • 5.1.3.2. Ongoing developments of PCR technology for improved pathogen testing
  • 5.1.4. Challenges
    • 5.1.4.1. Associated high cost of testing food and water
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. E. Coli Testing Market, by Testing

• 6.1. Introduction
• 6.2. Clinical
  • 6.2.1. Enzyme Immunoassays
  • 6.2.2. Polymerase Chain Reaction
• 6.3. Environmental
  • 6.3.1. Enzyme Substrate Methods
  • 6.3.2. Membrane Filtration
  • 6.3.3. Multiple Tube Fermentation

7. E. Coli Testing Market, by End-User

• 7.1. Introduction
• 7.2. Bottled Water Suppliers
• 7.3. Diagnostic Laboratories
• 7.4. Government Agencies
• 7.5. Home & Drinking Water Suppliers
• 7.6. Hospitals
• 7.7. Waste Water Treatment Agencies

8. Americas E. Coli Testing Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific E. Coli Testing Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa E. Coli Testing Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Bio-Rad Laboratories, Inc.
• 3. BioSpace, Inc.
• 4. BIOTOXICITY
• 5. Caisson Labs Inc.
• 6. Corning Incorporated
• 7. Cygnus Technologies by Maravai LifeSciences
• 8. Enzo Life Sciences, Inc.
• 9. F. Hoffmann-La Roche Ltd.
• 10. Intertek Group PLC
• 11. Lonza Group Ltd.
• 12. Merck & Co., Inc
• 13. Merck KGaA
• 14. SGS SA
• 15. Thermo Fisher Scientific Inc.